109 related articles for article (PubMed ID: 9620632)
1. Elimination of free radionuclide by a chelating agent improves tumor-to-nontumor ratios following radioimmunotargeting with antibody labeled with 67Ga.
Ryser JE; Rose K; Jones R; Pelegrin A; Donath A; Egeli R; Smith A; Offord RE
Nucl Med Biol; 1998 Apr; 25(3):261-5. PubMed ID: 9620632
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of 67Cu-labeled intact and fragmented anti-colon carcinoma monoclonal antibody MAb35.
Smith A; Alberto R; Blaeuenstein P; Novak-Hofer I; Maecke HR; Schubiger PA
Cancer Res; 1993 Dec; 53(23):5727-33. PubMed ID: 8242629
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
4. The effect of chelating agents on the distribution of monoclonal antibodies in mice.
Ward MC; Roberts KR; Westwood JH; Coombes RC; McCready VR
J Nucl Med; 1986 Nov; 27(11):1746-50. PubMed ID: 3464701
[TBL] [Abstract][Full Text] [Related]
5. Comparative biodistribution and radioimmunotherapy of monoclonal antibody RS7 and its F(ab')2 in nude mice bearing human tumor xenografts.
Stein R; Blumenthal R; Sharkey RM; Goldenberg DM
Cancer; 1994 Feb; 73(3 Suppl):816-23. PubMed ID: 8306265
[TBL] [Abstract][Full Text] [Related]
6. A newly designed radioimmunoconjugate releasing a hippurate-like radiometal chelate for enhanced target/non-target radioactivity.
Arano Y; Matsushima H; Tagawa M; Inoue T; Koizumi M; Hosono M; Sakahara H; Endo K; Konishi J; Yokoyama A
Nucl Med Biol; 1994 Jan; 21(1):63-9. PubMed ID: 9234265
[TBL] [Abstract][Full Text] [Related]
7. Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy.
Behr TM; Memtsoudis S; Sharkey RM; Blumenthal RD; Dunn RM; Gratz S; Wieland E; Nebendahl K; Schmidberger H; Goldenberg DM; Becker W
Int J Cancer; 1998 Aug; 77(5):787-95. PubMed ID: 9688314
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
[TBL] [Abstract][Full Text] [Related]
9. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and tumor localization of 111In-labeled unmodified and modified F(ab')2 fragments of human monoclonal IgM (16.88) in a nude mouse model.
Quadri SM; Siddiqui A; Klein JL; Vriesendorp HM
Nucl Med Biol; 1995 May; 22(4):413-23. PubMed ID: 7550017
[TBL] [Abstract][Full Text] [Related]
11. Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma.
Sharkey RM; Blumenthal RD; Behr TM; Wong GY; Haywood L; Forman D; Griffiths GL; Goldenberg DM
Int J Cancer; 1997 Jul; 72(3):477-85. PubMed ID: 9247292
[TBL] [Abstract][Full Text] [Related]
12. Preparation of a trivalent antigen-binding construct using polyoxime chemistry: improved biodistribution and potential for therapeutic application.
Werlen RC; Lankinen M; Offord RE; Schubiger PA; Smith A; Rose K
Cancer Res; 1996 Feb; 56(4):809-15. PubMed ID: 8631018
[TBL] [Abstract][Full Text] [Related]
13. Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.
Vogel CA; Bischof-Delaloye A; Mach JP; Pèlegrin A; Hardman N; Delaloye B; Buchegger F
Br J Cancer; 1993 Oct; 68(4):684-90. PubMed ID: 8398694
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.
Sharkey RM; Motta-Hennessy C; Pawlyk D; Siegel JA; Goldenberg DM
Cancer Res; 1990 Apr; 50(8):2330-6. PubMed ID: 2180566
[TBL] [Abstract][Full Text] [Related]
15. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
16. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
Yokota T; Milenic DE; Whitlow M; Wood JF; Hubert SL; Schlom J
Cancer Res; 1993 Aug; 53(16):3776-83. PubMed ID: 8339291
[TBL] [Abstract][Full Text] [Related]
17. Preparation of 67Ga-labeled antibodies using deferoxamine as a bifunctional chelate. An improved method.
Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Ohmomo Y; Arano Y; Yokoyama A
J Immunol Methods; 1987 Nov; 104(1-2):93-102. PubMed ID: 3316401
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
Massuger LF; Boerman OC; Corstens FH; Verheijen RH; Claessens RA; Poels LG; van den Broek WJ; Kenemans P
Anticancer Res; 1991; 11(6):2051-7. PubMed ID: 1776839
[TBL] [Abstract][Full Text] [Related]
19. Peptide linkers lead to modification of liver metabolism and improved tumor targeting of copper-67-labeled antibody fragments.
Novak-Hofer I; Zimmermann K; Schubiger PA
Cancer Biother Radiopharm; 2001 Dec; 16(6):469-81. PubMed ID: 11789024
[TBL] [Abstract][Full Text] [Related]
20. Potential and limitations of radioimmunodetection and radioimmunotherapy with monoclonal antibodies.
Zhu H; Baxter LT; Jain RK
J Nucl Med; 1997 May; 38(5):731-41. PubMed ID: 9170438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
